Merger Announced
Horizon Space Acquisition II Corp. and SL Bio merger
US$5.6bn equity value
Announced 13 Jan 2026
Advisers
Horizon Space Acquisition II Corp.
Acquirer
- Legal adviser
- Fairness opinion
- Target
- SL Bio
- Acquirer
- Horizon Space Acquisition II Corp.
- Buyer based in
- Cayman Islands
- Sector
- Biotech
Similar deals
- Biogen acquisition of Apellis Pharmaceuticals Mar 2026 · US$5.6bn · Biotech
- Eli Lilly and Company acquisition of Centessa Pharmaceuticals Mar 2026 · US$6.3bn · Biotech
- Merck & Co. acquisition of Terns Pharmaceuticals Mar 2026 · US$6.7bn · Biotech
- BioMarin acquisition of Amicus Therapeutics Dec 2025 · US$4.8bn · Biotech
- Eli Lilly and Company acquisition of Kelonia Therapeutics Apr 2026 · US$7bn · Biotech
Sources
- 13 Jan 2026 Definitive merger proxy statement (DEFM14A), Horizon Space Acquisition II Corp. sec.gov